MAMA:NASDAQMama's Creations, Inc. Analysis
Data as of 2026-06-26 - not real-time
$19.47
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mama's Creations is riding a wave of strong top‑line momentum, posting roughly 50% revenue growth and a 66% earnings surprise this quarter, while technical gauges show a bullish MACD and a price that is still climbing toward its recent high. However, the stock is deep in overbought territory and trades at a price far above its discounted cash‑flow estimate, suggesting limited upside in the near term. The company’s low beta and defensive consumer‑staples positioning temper the volatility, but the 30‑day price swings remain elevated, reflecting a market that is pricing both the growth narrative and valuation risk. Investors should weigh the earnings beat and product‑innovation pipeline against the stretched valuation and near‑term technical overextension before committing capital.
The upcoming investor conferences and new menu innovations provide a catalyst for continued revenue expansion, yet the current price level and lack of dividend return imply that a cautious, perhaps phased, approach is prudent.
The upcoming investor conferences and new menu innovations provide a catalyst for continued revenue expansion, yet the current price level and lack of dividend return imply that a cautious, perhaps phased, approach is prudent.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD but RSI in overbought zone
- Price near recent resistance level
- Recent earnings beat supporting momentum
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained 50% revenue growth and expanding product line
- Positive investor‑conference exposure and brand visibility
- Defensive consumer‑staples sector cushioning downside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation remains significantly above intrinsic DCF estimate
- Strong cash generation but modest free‑cash‑flow conversion
- Stable sector fundamentals offset by high price multiples
Key Metrics & Analysis
Financial Health
Revenue Growth49.70%
Profit Margin3.23%
P/E Ratio129.8
ROE14.93%
ROA8.46%
Debt/Equity24.74
P/B Ratio14.3
Op. Cash Flow$10.4M
Free Cash Flow$5.2M
Technical Analysis
TrendBullish
RSI77.5
Support$12.98
Resistance$20.18
MA 20$15.93
MA 50$14.91
MA 200$13.58
MACDBullish
VolumeStable
Fear & Greed Index87.96
Valuation
Fair Value$4.95
Target Price$22.00
Upside/Downside12.99%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.67
Volatility66.55%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.